Amid a surge in coronavirus cases, the Uttar Pradesh government Thursday decided to increase the duration of weekend lockdown by 24 hours, announcing that it will now cover Mondays too.
Drug firm Zydus Cadila on Thursday said it has applied for emergency use authorisation (EUA) with the Indian drug regulator for its three-dose COVID-19 vaccine ZyCoV-D, and plans to manufacture 10-12 crore doses annually.
US President Donald Trump thanked PM Modi for lifting curbs on the export of hydroxychloroquine.
This import duty exemption would remain in force till October 31 this year.
Fascinating new offerings from beloved auteurs as well as a steady supply of remakes and biopics colour the OTT scene this week. Sukanya Verma lists her picks.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.
Terming the situation as scary, Nath also said there was a shortage of Remdesivir injections used in the treatment of coronavirus, and alleged that the key anti-viral drug and oxygen were available only on paper and not in reality.
Hemant Shivsaran lists the number of projects the Modi government has announced since August to woo Gujarat voters.
The overall Air Quality Index (AQI) of Delhi stood at 398 at 11 am, worsening from 357 at 4 pm on Friday. It was 354 on Thursday, 271 on Wednesday, 302 on Tuesday and 312 on Monday (Diwali).
Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.
The Union health ministry on Tuesday said that aid received from other countries has been distributed in different states to help deal with the rising number of COVID-19 cases.
A second wave of Covid driven by the Delta variant engulfed the country in May-June bringing the health system to its knees and leaving people gasping for help.
Making the announcement at a press conference in Chandigarh, Sidhu, however, said he will assume charge the day Punjab will get a new advocate general.
If not contained quickly, it will have a knock-on effect in the world economy and disrupt global supply chains, Crisil analysts warned.
'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.
The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.
The Union health ministry is releasing funds for states and Union territories under the National Health Mission for implementation of phase 1 up to June 2020.
Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.
Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India.
Delhi Chief Minister and AAP National Convener Arvind Kejriwal unveiled the party's manifesto for the youth. The party, which is aiming to capture power in the state, will come out with separate manifestos for different sections of society.
I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.
The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.
This was Channi's first meeting with Shah after becoming the chief minister of the state.
His remarks came a day after AAP Punjab unit chief Bhagwant Mann took a dig at the cricketer-turned-politician and asked him to tweet about the 'funds' allegedly accepted by the ruling Congress from private power companies in the state.
The central government had announced that the vaccination for those above 18 years will begin across the country from May 1 as part of the third phase of the inoculation drive.
Pune-based Serum Institute of India (SII) is sitting on 200 million doses of Covishield that were manufactured in December and are set to expire in September. The company is likely to destroy these vaccines if nothing works out, Sohini Das reports.
Prime Minister Narendra Modi said on Wednesday that international travel should be made easier through mutual recognition of vaccine certificates, amid several countries adopting different sets of rules to allow foreigners to enter their territory in the wake of the COVID-19 pandemic.
Serum Institute has the capacity to make 250 million doses of Covishield monthly.
Giving details of coronavirus situation in the country, Bhushan said the previous highest surge has already been crossed and the trend is going upward and that is a cause for worry and that is something they continuously share with the states and UTs and try to help them tackle the pandemic in a more effective manner.
The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.
A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses.
PharmEasy, 1mg and Netmeds believe that their disruptive capabilities will power their brands despite the recent court ruling. The Drug Controller General of India recently directed all state FDAs to stop the online sale of medicines as per a Delhi high court order of last year.
Serum Institute of India, the world's largest vaccine manufacturer, has a licence to produce the shot and has already manufactured close to 50 million doses.
The situation is severe in North India as most of the logistics operation was manned by migrant labourers from Uttar Pradesh and Bihar. The problem with manpower is not only in courier and delivery services, but also at a shop level.
As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country and the target of exporting $126 million worth of pharmaceutical goods to the Taliban-ruling nation now depends on the future outcome. Udaya Bhaskar, director general of Pharmaceuticals Export Promotion Council of India (Pharmexcil) body under the Department of Commerce on Tuesday said as the situation is grim over there and India pharma exporters have cordial relations with Afghanistan. "The projected target for 2021-22 is $126.22 million.
The government allowed sugar companies and distilleries to make hand sanitizers using ethanol. Sugar companies supply ethanol to oil marketing companies for blending with petrol.
Though there is no official word, the sources said the government is not ready to give in to the indemnity demands of the US drug manufacturers against liabilities in case of adverse effects.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances